Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01017523 · ClinicalTrials.gov registry record · Phase 3
Diabetes Support Project: Couples Intervention
A Phase 3 study of Type 2 Diabetes, sponsored by State University of New York - Upstate Medical University.
- Completed
- Registry status
- Phase 3
- Development phase
- 268
- Enrollment target
- 2
- Study locations
NCT01017523 is a Phase 3 study of Type 2 Diabetes that has completed, run by State University of New York - Upstate Medical University. The registered enrollment target is 268 participants, below the 1,102-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (76% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT01017523, a Phase 3 study of Type 2 Diabetes, has completed, sponsored by State University of New York - Upstate Medical University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 268 participants
- Enrollment target
- 2
- Study locations
Study Summary
Research has shown that diabetes affects both the patient and family, and that support from family and partners helps diabetes patients manage their illness better. However, diabetes programs rarely involve the partner. The purpose of this study is to test an intervention that helps partners and patients who have type 2 diabetes better support each other. The intervention will be delivered over the telephone to reach more people. Our hypothesis is that an intervention that targets the couple has a greater effect on health and well-being of patients than one that targets the individual patient alone.
Conditions Studied
Interventions
- BEHAVIORAL Telephone support and behavior change
- OTHER Diabetes self-management education
Study Locations (2)
California
- University of California, San Francisco - San Francisco
New York
- SUNY Upstate Medical University, Dept. of Psychiatry - Syracuse
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 268 participants |
| Start Date | 2010-01 |
| Est. Completion | 2015-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01017523
The ClinicalTrials.gov registry entry for NCT01017523 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 268 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,102-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (76% lower). The listed sponsor is State University of New York - Upstate Medical University, which has 113 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Type 2 Diabetes appearing as the primary indexed condition, and to 2 interventions - of which Telephone support and behavior change is the first listed.
NCT01017523 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, New York.
Frequently Asked Questions
What is clinical trial NCT01017523 about?
NCT01017523 is a clinical study titled "Diabetes Support Project: Couples Intervention". Research has shown that diabetes affects both the patient and family, and that support from family and partners helps diabetes patients manage their illness better. However, diabetes programs rarely involve the partner. The purpose of this study is to test an intervention that helps partners and pat...
What is the current status of trial NCT01017523?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 268 participants. The study started on 2010-01. Estimated completion is 2015-01.
What conditions does trial NCT01017523 study?
This clinical trial studies the following conditions: Type 2 Diabetes.
What interventions are being tested in trial NCT01017523?
The interventions under investigation include: Telephone support and behavior change (BEHAVIORAL), Diabetes self-management education (OTHER).
Who is sponsoring clinical trial NCT01017523?
This trial is sponsored by State University of New York - Upstate Medical University, which has 113 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01017523 being conducted?
This trial has 2 study locations across California, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 2 Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Master Protocol for Orforglipron (LY3502970) in Participants With Obesity or Overweight With and Without Type 2 Diabetes
RECRUITING · Phase 3
-
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Type 2 Diabetes
RECRUITING · Phase 3
-
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
RECRUITING · Phase 3
-
Effects of Modulators of Gluconeogenesis, Glycogenolysis and Glucokinase Activity
ACTIVE NOT RECRUITING · Phase 3
-
Effect of Retatrutide Compared With Placebo in Participants With Type 2 Diabetes and Moderate or Severe Renal Impairment, With Inadequate Glycemic Control on Basal Insulin, With or Without Metformin and/or SGLT2 Inhibitor (TRANSCEND-T2D-3)
ACTIVE NOT RECRUITING · Phase 3
-
Weight Loss in People Living With Overweight or Obesity and Type 2 Diabetes Following Treatment With Cagrilintide
ACTIVE NOT RECRUITING · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.